Meige's syndrome
(Redirected from Craniofacial dystonia)
Meige's Syndrome is a rare neurological movement disorder characterized by involuntary and often forceful contractions of the muscles of the jaw and tongue (dystonia) and involuntary muscle spasms and contractions or tics of the muscles around the eyes (blepharospasm).
Symptoms[edit | edit source]
The symptoms of Meige's Syndrome typically begin between the ages of 30 and 70 years, and may include involuntary eye blinking, forceful closing of the eyes, jaw muscle discomfort, difficulty opening the mouth, and speech and swallowing difficulties due to muscle spasms. The severity and expression of these symptoms can vary widely among affected individuals.
Causes[edit | edit source]
The exact cause of Meige's Syndrome is unknown. However, it is believed to result from a combination of genetic and environmental factors. Some researchers believe that it may be related to abnormalities or damage in certain areas of the brain that control movement.
Diagnosis[edit | edit source]
Diagnosis of Meige's Syndrome is based on a thorough clinical evaluation, a detailed patient history, and a variety of specialized tests. These tests may include blood tests, imaging studies such as MRI or CT scan, and possibly a lumbar puncture.
Treatment[edit | edit source]
There is currently no cure for Meige's Syndrome. Treatment is symptomatic and may include medications, botulinum toxin injections, deep brain stimulation, and/or surgery. Physical therapy may also be beneficial for some individuals.
Prognosis[edit | edit source]
The prognosis for individuals with Meige's Syndrome varies. While the condition is not life-threatening, it can significantly impact an individual's quality of life. However, with appropriate treatment and management, many individuals with Meige's Syndrome are able to lead productive lives.
See Also[edit | edit source]
References[edit | edit source]
Meige's syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD